Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
NorthWestern Energy
NWE
$4.41B
| $1.53M | ﹤0.01% |
25,026
-29,074
| -54% | -$1.77M |
|
2402
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
| $1.53M | ﹤0.01% |
27,800
-48,600
| -64% | -$2.7M |
|
2403
Noodles & Co
NDLS
$109M
| $1.53M | ﹤0.01% |
48,900
-13,525
| -22% | -$528K |
|
|
NSH
2404
DELISTED
NuStar GP Holdings LLC
NSH
| $1.52M | ﹤0.01% |
62,200
-6,100
| -9% | -$158K |
|
2405
Navigator Holdings
NVGS
$1.29B
| $1.52M | ﹤0.01% |
182,800
+116,600
| +176% | +$1.16M |
|
|
TPIC
2406
DELISTED
TPI Composites
TPIC
| $1.51M | ﹤0.01% |
81,800
+27,000
| +49% | +$486K |
|
|
GEN
2407
DELISTED
Genesis Healthcare, Inc.
GEN
| $1.51M | ﹤0.01% |
866,700
+179,700
| +26% | +$382K |
|
2408
Harvard Bioscience
HBIO
$30.1M
| $1.5M | ﹤0.01% |
59,000
+2,950
| +5% | +$73K |
|
|
PBNC
2409
DELISTED
PARAGON COMMERCIAL CORPORATION
PBNC
| $1.5M | ﹤0.01% |
28,665
+23,665
| +473% | +$1.24M |
|
2410
Darling Ingredients
DAR
$10.6B
| $1.5M | ﹤0.01% |
95,360
-21,531
| -18% | -$333K |
|
2411
Kimco Realty
KIM
$16.4B
| $1.49M | ﹤0.01% |
81,300
-2,375,529
| -97% | -$46.6M |
|
|
USAP
2412
DELISTED
Universal Stainless & Alloy
USAP
| $1.49M | ﹤0.01% |
76,500
+25,800
| +51% | +$464K |
|
|
UBFO
2413
DELISTED
United Security Bancshares
UBFO
| $1.49M | ﹤0.01% |
160,601
-2,182
| -1% | -$19.1K |
|
|
MIK
2414
DELISTED
Michaels Stores, Inc
MIK
| $1.48M | ﹤0.01% |
79,700
-439,700
| -85% | -$9.15M |
|
2415
Baytex Energy
BTE
$3.06B
| $1.47M | ﹤0.01% |
606,097
-8,700
| -1% | -$25.9K |
|
2416
Global Ship Lease
GSL
$1.52B
| $1.47M | ﹤0.01% |
150,638
+1,325
| +0.9% | +$13.7K |
|
|
SOL
2417
DELISTED
Emeren Group
SOL
| $1.47M | ﹤0.01% |
601,360
+45,200
| +8% | +$115K |
|
|
WTT
2418
DELISTED
Wireless Telecom Group, Inc.
WTT
| $1.46M | ﹤0.01% |
914,100
+57,000
| +7% | +$86.2K |
|
2419
ClearOne Inc
CLRO
$14.3M
| $1.46M | ﹤0.01% |
10,340
-793
| -7% | -$118K |
|
|
HOUS
2420
DELISTED
Anywhere Real Estate
HOUS
| $1.46M | ﹤0.01% |
44,900
-530,000
| -92% | -$16M |
|
|
ARIS
2421
DELISTED
ARI Network Services, Inc.
ARIS
| $1.45M | ﹤0.01% |
206,300
+52,300
| +34% | +$291K |
|
2422
Dynagas LNG Partners
DLNG
$138M
| $1.45M | ﹤0.01% |
95,000
-175,126
| -65% | -$2.76M |
|
2423
Geron
GERN
$943M
| $1.45M | ﹤0.01% |
523,380
+162,233
| +45% | +$431K |
|
2424
Westlake Chemical Partners
WLKP
$761M
| $1.45M | ﹤0.01% |
58,421
-25,114
| -30% | -$621K |
|
2425
Lifeway Foods
LWAY
$390M
| $1.45M | ﹤0.01% |
154,700
-8,000
| -5% | -$77.8K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.